thisdrug what a medicine's name tells you

WHO naming stem · suffix · 26 listed names

-tecan

antineoplastics, topoisomerase I inhibitors

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -tecan as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -tecan. So the letters tecan sit at the end of the name (…tecan).

All 26 names WHO lists under -tecan

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. afeletecan
  2. atiratecan
  3. belotecan
  4. cositecan
  5. davamotecan pegadexamer
  6. delimotecan
  7. diflomotecan
  8. elemotecan
  9. etirinotecan pegol
  10. exatecan
  11. exatecan alideximer
  12. firtecan peglumer
  13. firtecan pegol
  14. gimatecan
  15. irinotecan
  16. labetuzumab govitecan
  17. locnartecan
  18. lurtotecan
  19. mureletecan
  20. namitecan
  21. pegamotecan
  22. rubitecan
  23. sacituzumab govitecan
  24. tenifatecan
  25. topotecan
  26. trastuzumab deruxtecan

Decode another name

Decoded

exatecan

Listed INNCarries the WHO stem -tecan

  • -tecanend of the nameWHO lists it hereWHO definition: antineoplastics, topoisomerase I inhibitors

“exatecan” is an INN that WHO lists under -tecan in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -tecan (Part II B) and the 26 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.